Process for preparing intermediates for synthesis of antifungal agents

A compound and chiral compound technology, applied in bulk chemical production, organic chemistry, fermentation, etc., can solve the problems of high cost and low efficiency of prior art methods for tosylate intermediates
CN1057089CInactive Publication Date: 2000-10-04SCHERING AG

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
SCHERING AG
Publication Date
2000-10-04
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
Patent Text Reader

Abstract

Disclosed is a process for preparing chiral compounds of formula (I) wherein: X<1> and X<2> are independently F or Cl; and E is -SO2R<2>, wherein R<2> is C1-C6 alkyl, -C6H4CH3 or -CF3; its enantiomer and racemates thereof, useful in the synthesis of tetrahydrofuran azole antifungals. Novel compounds of formula (II) or (III) wherein: X<1> and X<2> are independently F or Cl; B represents -C(O)Q* or -CH2OR'; Q* represents a chiral auxiliary group; R'' represents a hydroxy protecting group; and A represents Cl, Br, I, triazolyl or imidazolyl; are also disclosed.
Need to check novelty before this filing date? Find Prior Art

Description

background of the invention

[0001] The invention relates to a preparation method of a chiral intermediate used for preparing trisubstituted tetrahydrofurantriazole or imidazole antifungal agent.

[0002] WIPO publications WO 89 / 04829 and USP 5,039,676 disclose (±)-cis and (±)-trans antifungal compounds represented by the formula: Wherein: a is N or CH; X is F or Cl; Z is lower alkyl, (C 2 -C 8 ) alkanoyl or 2-lower alkyl-3-oxo-1,2,4-triazol-4-yl substituted phenyl. Examples of such compounds are (±)-cis and (±)-trans-1-[4-[[2-(2,4-difluorophenyl)-2-[(1H-1,2,4-tri Azol-1-yl)methyl]tetrahydro-4-furyl]methoxy]phenyl]-4-(1-methylethyl)piperazine.

[0003] In addition, PCT International Application PCT / US 92 / 08981 relates to antifungal compounds represented by the following formula and pharmaceutically acceptable salts thereof: Wherein: X is both F or Cl, or one X is F, and the other is Cl; Y is a group shown in the following formula: where: R 1 for (C 1 -C 10 ) Alkyl, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More